Cambridge Investment Research Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.37M Buy
54,803
+331
+0.6% +$50.7K 0.02% 688
2025
Q4
$7.51M Sell
54,472
-1,629
-3% -$213K 0.02% 714
2025
Q3
$7.19M Buy
56,101
+3,239
+6% +$395K 0.02% 720
2025
Q2
$6.4M Sell
52,862
-5,603
-10% -$632K 0.02% 723
2025
Q1
$6.52M Sell
58,465
-46,462
-44% -$4.95M 0.02% 672
2024
Q4
$10.2M Buy
104,927
+52,060
+98% +$5.55M 0.03% 484
2024
Q3
$6.08M Buy
52,867
+1,827
+4% +$207K 0.02% 710
2024
Q2
$5.43M Sell
51,040
-6,373
-11% -$640K 0.02% 713
2024
Q1
$5.55M Buy
57,413
+1,640
+3% +$168K 0.02% 694
2023
Q4
$5.63M Sell
55,773
-7,807
-12% -$754K 0.02% 644
2023
Q3
$6.48M Sell
63,580
-20,147
-24% -$2.05M 0.03% 547
2023
Q2
$8.45M Buy
83,727
+29,488
+54% +$2.95M 0.04% 440
2023
Q1
$4.99M Sell
54,239
-2,065
-4% -$180K 0.02% 627
2022
Q4
$5.11M Sell
56,304
-99
-0.2% -$8.34K 0.03% 600
2022
Q3
$4.29M Sell
56,403
-823
-1% -$68.2K 0.02% 636
2022
Q2
$4.84M Buy
57,226
+2,986
+6% +$262K 0.03% 600
2022
Q1
$4.76M Sell
54,240
-106
-0.2% -$9.18K 0.02% 654
2021
Q4
$4.75M Buy
54,346
+4,162
+8% +$346K 0.02% 660
2021
Q3
$4.1M Sell
50,184
-4,035
-7% -$363K 0.02% 699
2021
Q2
$4.95M Sell
54,219
-4,071
-7% -$363K 0.02% 623
2021
Q1
$4.98M Buy
58,290
+651
+1% +$58.4K 0.03% 563
2020
Q4
$5.44M Sell
57,639
-9,033
-14% -$789K 0.03% 494
2020
Q3
$5.8M Buy
66,672
+3,594
+6% +$311K 0.04% 416
2020
Q2
$5.51M Buy
63,078
+700
+1% +$60.4K 0.04% 410
2020
Q1
$5.14M Buy
62,378
+5,355
+9% +$478K 0.05% 356
2019
Q4
$5.4M Buy
57,023
+3,816
+7% +$342K 0.04% 435
2019
Q3
$4.62M Buy
53,207
+5,529
+12% +$496K 0.04% 438
2019
Q2
$4.35M Sell
47,678
-41,698
-47% -$3.53M 0.04% 439
2019
Q1
$7.7M Buy
89,376
+36,624
+69% +$2.94M 0.07% 251
2018
Q4
$4.06M Buy
52,752
+2,317
+5% +$180K 0.04% 391
2018
Q3
$3.89M Buy
50,435
+1,485
+3% +$110K 0.04% 444
2018
Q2
$3.31M Sell
48,950
-3,567
-7% -$246K 0.04% 467
2018
Q1
$3.81M Buy
52,517
+1,823
+4% +$139K 0.04% 391
2017
Q4
$3.81M Buy
50,694
+799
+2% +$60.3K 0.04% 380
2017
Q3
$3.84M Buy
49,895
+5,780
+13% +$437K 0.05% 331
2017
Q2
$3.3M Buy
44,115
+897
+2% +$63.6K 0.05% 356
2017
Q1
$2.88M Sell
43,218
-405
-0.9% -$27K 0.05% 348
2016
Q4
$2.85M Buy
43,623
+3,743
+9% +$243K 0.05% 328
2016
Q3
$2.82M Buy
39,880
+119
+0.3% +$8.67K 0.05% 325
2016
Q2
$2.94M Buy
39,761
+3,377
+9% +$233K 0.06% 290
2016
Q1
$2.36M Buy
36,384
+974
+3% +$66.3K 0.05% 316
2015
Q4
$2.73M Sell
35,410
-631
-2% -$50.1K 0.06% 278
2015
Q3
$2.97M Buy
36,041
+163
+0.5% +$14.5K 0.09% 229
2015
Q2
$3.16M Buy
35,878
+3,271
+10% +$300K 0.09% 225
2015
Q1
$2.88M Buy
32,607
+472
+1% +$41.9K 0.08% 244
2014
Q4
$2.67M Buy
32,135
+780
+2% +$64.7K 0.08% 231
2014
Q3
$2.65M Buy
31,355
+6,219
+25% +$503K 0.08% 252
2014
Q2
$2.04M Buy
25,136
+708
+3% +$55.7K 0.07% 270
2014
Q1
$1.86M Sell
24,428
-2,484
-9% -$181K 0.07% 274
2013
Q4
$1.94M Buy
26,912
+2,603
+11% +$181K 0.08% 242
2013
Q3
$1.67M Buy
24,309
+1,939
+9% +$128K 0.07% 254
2013
Q2
$1.42M Buy
+22,370
New +$1.46M 0.07% 249

Other funds holding NVS